Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2
Tóm tắt
This case report describes the clinical characteristics of a 50-year-old woman that developed SARS-CoV-2 pneumonia and was admitted at the COVID-19 dedicated unit where she developed neurological symptoms 10 days after admission. After neurological examination, including a panel of blood cerebrospinal fluid biomarkers, a diagnosis of Miller Fisher syndrome (MFS) was hypothesized and intravenous immunoglobulin therapy (IVIG) was initiated. Fourteen days after the start of IVIG treatment, the patient has been discharged at home with the resolution of respiratory symptoms and only minor hyporeflexia at the lower limbs, without any side effect.
Tài liệu tham khảo
Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11:995–998. https://doi.org/10.1021/acschemneuro.0c00122
Polo A, Manganotti P, Zanette G, De Grandis D (1992) Polyneuritis cranialis: clinical and electrophysiological findings. J Neurol Neurosurg Psychiatry 55:398–400. https://doi.org/10.1136/jnnp.55.5.398
Pusch E, Renz H, Skevaki C (2018) Respiratory virus-induced heterologous immunity: part of the problem or part of the solution? Allergo J Int 27:79–96. https://doi.org/10.1007/s40629-018-0056-0
Sellers SA, Hagan RS, Hayden FG, Fischer WA 2nd (2017) The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses 11:372–393. https://doi.org/10.1111/irv.12470
Wakerley BR, Uncini A, Yuki N (2014) Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol 10:537–544. https://doi.org/10.1038/nrneurol.2014.138
Wattanasit P, Sathirapanya P (2020) Anti-ganglioside antibody-negative Miller Fisher and AMSAN variant Guillain-Barré overlap syndrome. Case Rep Neurol 12:92–96
Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19:383–384. https://doi.org/10.1016/S1474-4422(20)30109-5